Targeting Natural Products for the Treatment of COVID-19 – An Updated Review

Author(s): Ramachandra R. Pamuru, Naveen Ponneri, Amooru G. Damu, Ramakrishna Vadde*

Journal Name: Current Pharmaceutical Design

Volume 26 , Issue 41 , 2020

Become EABM
Become Reviewer
Call for Editor


Background: Coronavirus disease 2019 (COVID-19) is an ongoing, rapidly spreading pandemic caused by Severe Acute Respiratory Syndrome Coronavirus2 (SARS-CoV2). Among all the infected countries around the globe as of now (June 15, 2020), the total confirmed positive cases reported are 7,805,148, with the death of 431,192. At present, no specialized treatments evolved to cure COVID-19. Its treatment is symptomatic. Though huge efforts are being made to produce potential therapies to scuffle COVID-19, no drug has been discovered so far.

Objective: Natural products have been playing a significant role in disease control since ancient days. These products serve as templates for designing new anti-microbial agents with a different mechanism of action and also open a door for investigation of effective anti-viral drugs to combat COVID-19. By focusing on this, the authors have narrated the basic structure, infection, and pathogenesis of SARS-CoV2 virus in humans and also reported various natural products or plant-based extracts/bioactive compounds tested against coronaviruses like SARS and MERS, as these viruses are structurally similar to SARS-CoV2 and can be used in designing novel drug against this virus.

Conclusion: The natural products having the potential to combat SARS, MERS, and other viruses reviewed in this review article might have anti-viral activities against the SARS-CoV2 virus and can be used directly for further preclinical studies. Therefore, all efforts should be focused on overcoming this serious problem to save many people's lives all over the world.

Keywords: COVID-19, SARS-CoV2, pathogenesis, natural products, anti-viral property, therapy.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Published on: 12 December, 2020
Page: [5278 - 5285]
Pages: 8
DOI: 10.2174/1381612826666200903122536
Price: $65

Article Metrics

PDF: 33